lukasz kuryk, phd, mba
National Institute of Public Health (Poland)
Warsaw, Poland
Associate Editor
Pharmacology of Anti-Cancer Drugs
National Institute of Public Health (Poland)
Warsaw, Poland
Associate Editor
Pharmacology of Anti-Cancer Drugs
Kagoshima University
Kagoshima, Japan
Associate Editor
Neuropharmacology
The Chinese University of Hong Kong
Shatin, China
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
Kyungpook National University
Daegu, Republic of Korea
Associate Editor
Inflammation Pharmacology
University of Catania
Catania, Italy
Associate Editor
Experimental Pharmacology and Drug Discovery
BAGI Biosciences
Hong Kong, Hong Kong, SAR China
Associate Editor
Inflammation Pharmacology
Principe Felipe Research Center (CIPF)
Valencia, Spain
Associate Editor
Neuropharmacology
Hainan University
Haikou, China
Associate Editor
Experimental Pharmacology and Drug Discovery
University of SĂŁo Paulo
SĂŁo Paulo, Brazil
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
University of Foggia
Foggia, Italy
Associate Editor
Drugs Outcomes Research and Policies
University of British Columbia
Vancouver, Canada
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
Gilead (United States)
Foster City, United States
Associate Editor
Drug Metabolism and Transport
University of Pretoria
Pretoria, South Africa
Associate Editor
Ethnopharmacology
University of Birmingham
Birmingham, United Kingdom
Associate Editor
Gastrointestinal and Hepatic Pharmacology
Swansea University
Swansea, United Kingdom
Associate Editor
Pharmacogenetics and Pharmacogenomics
College of Pharmacy, University of Florida
Gainesville, United States
Associate Editor
Pharmacogenetics and Pharmacogenomics